Splenoportocholangiography is a research method that is used to diagnose diseases of the liver and spleen. It consists of injecting a contrast agent into the portal vein and bile ducts, after which an X-ray examination is performed to obtain images of the organs.
A splenoportocholangiogram can detect various liver diseases, such as cirrhosis, hepatitis, liver cancer and others. This method can also help in diagnosing diseases of the spleen, such as splenic infarction and splenic vein thrombosis.
To perform splenoportocholangiography, a special catheter is used, which is inserted into the portal vein through the femoral artery. After this, a contrast agent is injected through a catheter into the portal vein, which then enters the bile ducts.
After the administration of a contrast agent, an X-ray examination is performed, which allows us to obtain images of the organs. The examination lasts about 30 minutes and can be performed either under local anesthesia or without it.
Despite the fact that splenoportocholangiography is a fairly invasive research method, it allows one to obtain accurate data on the condition of the liver and spleen, which is important for the diagnosis and treatment of many diseases.
Spleno-porto-cholangiogram (old. Spleno-porto-cholangiography) is an X-ray contrast study of the biliary tract and portal system using contrast agents. Its results make it possible to obtain information about the state of the biliary system, the liver, its vessels and hepatic ducts, as well as to detect possible damage to these organs. The study is prescribed if tumors and other pathological processes in the liver and biliary tract are suspected.